Kimberly-Clark CorporationNasdaq: KMB
Consumer Staples · Household Products
$102.56
+1.07%
Vol: 2.8M
Research Digest
Friday, June 19, 2026
Piper Sandler raised its Kimberly-Clark price target to $121 from $115, adding to bullish analyst sentiment around the company's $3 billion productivity program and pending Kenvue merger.
Piper Sandler raised its price target on Kimberly-Clark to $121 from $115, with the move reported within the last 24 hours. The upgrade comes as the stock has shown short-term momentum, posting a roughly 5.5% seven-day return and about 7.5% over 30 days, trading near $102.34 for a market cap of about $34 billion. Investor attention has centered on Kimberly-Clark's $3 billion productivity program, higher capital spending on network optimization, and anticipated supply chain benefits from its pending acquisition of Kenvue, expected to close in the second half of 2026. RBC Capital also maintains a Buy rating. The key risk is execution on the productivity plan and integration of the large Kenvue deal, alongside consumer-staples demand softness. The dividend aristocrat yields roughly 4.85%, supporting income-focused interest.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Kimberly-Clark holds annual meeting; controller departs; Kenvue deal integrationNeutral▶
Annual Meeting May 14: all directors re-elected, Deloitte ratified, executive pay approved; independent chair proposal rejected. VP/Controller Andrew Scribner departing May 22; CFO Nelson Urdaneta takes interim principal accounting officer role. Declared $1.28/share quarterly dividend May 15. Building 1M sq ft manufacturing facility (~500 jobs). Kenvue acquisition synergies to integrate in 2H 2026. Huggies launched Natural Born Fighters campaign May 6. Stock $96.47 May 19; analysts reiterated Buy with $120 PT on May 11.
May 20No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 19No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 18Kimberly-Clark held annual meeting May 14 with all directors elected, declared $1.28 quarterly dividend amid Kenvue acquisition integration plans.Mixed▶
Kimberly-Clark held its 2026 Annual Meeting of Stockholders on May 14, 2026, where shareholders elected all nominated directors, ratified Deloitte & Touche LLP as auditor, and gave advisory approval to executive compensation. A shareholder proposal requiring an independent board chair was rejected. The board declared a regular quarterly dividend of $1.28 per share on the same day. The firm is set to integrate Kenvue's consumer health portfolio in the second half of 2026 following the $48.7 billion acquisition. Earlier in May, the company announced VP and Controller Andrew Scribner's departure effective May 22, 2026, with CFO Nelson Urdaneta temporarily assuming principal accounting officer duties. EPS projections for 2026 were lowered from $8.00 to $7.85, with 71% of analysts suggesting Hold. Shares opened May 18 at $97.43.
May 15Kimberly-Clark announced Controller Andrew Scribner departure effective May 22 with CFO Urdaneta taking interim accounting officer role, while pending $48.7B Kenvue acquisition gained India CCI approval.Mixed▶
Kimberly-Clark announced May 1 that VP and Controller Andrew Scribner will depart effective May 22, 2026; CFO Nelson Urdaneta will temporarily assume principal accounting officer duties. Board declared a regular quarterly dividend of $1.28/share. Q1 2026 results exceeded expectations with 2.5% organic growth, 3% volume/mix growth, and revenue of $4.16B (vs $4.09B consensus). The pending $48.7B Kenvue acquisition received India CCI approval; closing anticipated 2H 2026 pending remaining regulatory clearance. Barclays maintained Equal-Weight and cut PT to $99 from $105. Consensus is Hold across 14 analysts with FY26 EPS estimates lowered to $7.85 from $8.00. New Kleenex Snap & Go format rolled out across US retailers. Risk: input cost pressures, 5.29% dividend sustainability questioned, integration execution on Kenvue.
May 14Kimberly-Clark holds annual shareholder meeting May 14 with Kenvue merger integration underway and controller Andrew Scribner exiting May 22.Mixed▶
Kimberly-Clark is holding its 2026 annual shareholder meeting on May 14. On May 1, the company announced VP and Controller Andrew Scribner will leave on May 22 to pursue other opportunities, with CFO Nelson Urdaneta temporarily taking on principal accounting officer duties. Scribner sold his remaining 4,095 shares on May 6, reducing his holdings to zero. Kimberly-Clark's Q1 2026 results topped expectations with 3% volume/mix growth, productivity gains, and continued preparation for the $48.7B Kenvue acquisition (shareholder-approved January 29, 2026) that will create a $32B global health and wellness leader. Huggies launched its "Natural Born Fighters" NICU campaign on May 6 with athletes Derick Hall and Allison Schmitt. Shares trading around $97.04 on May 14. 14 analysts rate Hold consensus.
May 13Kimberly-Clark's VP & Controller Andrew Scribner departs May 22 with CFO assuming principal accounting officer duties, as the company progresses on its $48.7B Kenvue acquisition.Neutral▶
Kimberly-Clark announced on May 1, 2026, that VP & Controller Andrew Scribner will leave the company effective May 22, 2026; CFO Nelson Urdaneta will temporarily assume principal accounting officer duties. Scribner sold 4,095 shares on May 6 for proceeds of $401,310. KMB shares fluctuated between $95.32 and $97.76 on May 12. The company is actively progressing its pending $48.7 billion acquisition of Kenvue, with leadership changes positioned as part of operational restructuring intended to enhance efficiency. Kimberly-Clark also announced it will present at the Barclays 18th Annual Americas Select Conference on May 6, 2026. Analyst consensus across 14 covering firms remains Hold (71% Hold, 14% Strong Buy, 7% Buy).
May 12Kimberly-Clark announces controller departure and interim successor as Kenvue $48.7B acquisition progressesMixed▶
Kimberly-Clark announced a Controller departure and interim successor on May 5. On May 6, Controller Andrew Scribner sold 4,095 shares (~$401K). The $48.7B Kenvue acquisition is progressing, with the company having outlined a post-closing organizational structure and key leadership on April 15. Q1 2026 net sales were $4.2B (up 2.7%) with organic sales growth of 2.5%, reaffirming the FY26 outlook. Stock at ~$99.19 with reported intrinsic discount of 36.97%. Consensus is Hold with $113.29 average price target. Analysts cite input cost pressures and 5.29% dividend sustainability concerns.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CLCOLGATE | $89.77 | -0.89% | — | 23.5x | 0.32 | $76.1B |
| KMBKIMBERLY | $102.56 | +1.07% | — | 15.2x | 0.28 | $38.1B |
| CHDCHURCH | $95.77 | -1.69% | — | 24.1x | 0.47 | $23.4B |
| CLXCLOROX | $95.98 | +1.06% | — | 15.6x | 0.53 | $11.8B |
| WMTWALMART | $117.25 | -0.75% | — | 34.0x | 0.60 | $890.0B |
| COSTCOSTCO | $952.10 | -1.40% | — | 42.1x | 0.87 | $422.0B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.